Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 73.89B 82.15B P/E ratio 2024 *
24.7x
P/E ratio 2025 * 20.7x
Enterprise value 80.8B 89.83B EV / Sales 2024 *
3.77x
EV / Sales 2025 * 3.49x
Free-Float
29.72%
Yield 2024 *
1.36%
Yield 2025 * 1.51%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.28%
1 week-3.07%
Current month-3.07%
1 month+4.89%
3 months-0.84%
6 months+7.68%
Current year+18.29%
More quotes
1 week
169.15
Extreme 169.15
176.55
1 month
162.05
Extreme 162.05
177.00
Current year
140.50
Extreme 140.5
177.00
1 year
134.30
Extreme 134.3
177.00
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
65.52
Extreme 65.52
231.50
More quotes
Director TitleAgeSince
Chief Executive Officer 63 20-07-12
Director of Finance/CFO 54 19-04-25
Chief Tech/Sci/R&D Officer - 20-10-31
Manager TitleAgeSince
Director/Board Member - -
Director/Board Member 61 12-04-30
Director/Board Member 75 14-05-08
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.21%-3.07%+1.67%-17.26%81.92B
-0.06%-3.70%+21.36%-19.24%11.74B
-6.45%-4.74%+95.90%+134.03%7.37B
-3.26%-9.57%+27.92%-16.80%6.1B
+5.42%+6.59%-23.39%-55.02%2.2B
+0.19%-5.27%+8.22%+11.93%2.04B
+1.14%-6.96%-11.70%+46.00%2B
-1.77%-1.77%+8.25%+25.20%1.89B
-.--%-.--% - - 1.64B
-7.97%-11.69%-54.00%-17.38%1.57B
Average -1.28%-3.17%+8.25%+10.16% 11.85B
Weighted average by Cap. -0.40%-3.35%+9.73%-6.33%
See all sector performances
2024 *2025 *
Net sales 21.41B 23.8B 22.58B 25.1B
Net income 2.99B 3.33B 3.56B 3.95B
Net Debt 6.91B 7.69B 5B 5.56B
More financial data * Estimated data
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Employees
62,176
Calendar
More about the company
Date Price Change Volume
24-09-06 170.45 +0.29% 8,763
24-09-05 169.95 -1.28% 330,089
24-09-04 172.15 -1.03% 282,712
24-09-03 173.95 -0.71% 148,354
24-09-02 175.20 -0.37% 108,085

Delayed Quote Xetra, September 06, 2024 at 03:15 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
169.95EUR
Average target price
185.94EUR
Spread / Average Target
+9.41%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW